Previous reports demonstrated that the C/EBPβ protein could be upregulated by BCR-ABL1 through STAT5 activation in CML cells, contributing to the signaling transduction of BCR-ABL159. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.